Financial Difficulty in Patients with Blood Cancer

Inclusion Criteria

• Patient Eligibility Criteria: * Documentation of disease: Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) and/or multiple myeloma (MM). * Patients’ medical records must be available to the registering institution. * Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who: ** Are presently being treated with infused or orally-administered anticancer therapy, OR ** Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR ** Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment. * Not currently enrolled in a clinical trial in which drug is supplied by the study, or planning to enroll in a clinical trial within 12 weeks of registration. * Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible. * Patients must be able to read and comprehend English or Spanish. * Age ≥ 18 years Site Eligibility Criteria: * Intent to complete the Practice Survey * Access to patient medical records: Registering institution must have access to patient medical records, either on site or via request from other institutions, if recruiting patients at a site (as medical abstraction is required for collecting study data). * Sites seeking to enroll Spanish- speaking patients must have Spanish speaking staff on site or through the use of a translation service to be able to conduct the informed consent discussion in Spanish. Physician Eligibility Criteria: * The physician currently treats patients with chronic lymphocytic leukemia (CLL) and/or multiple myeloma (MM). * The physician is a treating physician at a site which has opened this protocol (LCCC 2063) and/or a site which opened the Alliance protocol (A231602CD). Eligible physicians do not need to have their own patients enrolled on this to protocol or on to A231602CD.